Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Growth of geographic atrophy in the comparison of age-related macular degeneration treatments trials.

Ophthalmology - 1 Apr 2015

Grunwald Juan E, Pistilli Maxwell, Ying Gui-Shuang, Maguire Maureen G, Daniel Ebenezer, Martin Daniel F

Abstract excerpt

PURPOSE: To evaluate the growth of geographic atrophy (GA) during anti-vascular endothelial growth factor (VEGF) therapy. DESIGN: Cohort within a clinical trial. PARTICIPANTS: Patients included in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT). METHODS: Participants were randomly assigned to injections of ranibizumab or bevacizumab and to a 2-year dosing regimen of monthly or pro re...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bevacizumab
Share to Complement C3
Share to Geographic Atrophy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to High-Temperature Requirement A Serine Peptidase 1

Share to Intravitreal Injections

Share to Photography

Share to Toll-Like Receptor 3

Share to Wet Macular Degeneration

Source

Open in PubMed Open full text

Identifiers

PMID: 25542520
DOI: 10.1016/j.ophtha.2014.11.007
PMCID: PMC4372487

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Growth of geographic atrophy in the comparison of age-related macular degeneration treatments trials.PMID 25542520Read ↗

Incidence and progression of geographic atrophy: observations from a population-based cohort.Semantic proximity Read ↗

Assessment of Novel Genome-Wide Significant Gene Loci and Lesion Growth in Geographic Atrophy Secondary to Age-Related Macular DegenerationSemantic proximity Read ↗

Geographic atrophy: where we are now and where we are goingSemantic proximity Read ↗

Informing Endpoints for Clinical Trials of Geographic AtrophySemantic proximity Read ↗

Clinical and genetic factors associated with progression of geographic atrophy lesions in age-related macular degeneration.Semantic proximity Read ↗

Progression of geographic atrophy and genotype in age-related macular degeneration.Semantic proximity Read ↗

Investigating Macular Tissue Integrity Index as a Novel Biomarker in Geographic AtrophySemantic proximity Read ↗

Critical Dependence on Area in Relationship between ARMS2/HTRA1 Genotype and Faster Geographic Atrophy Enlargement: Age-Related Eye Disease Study 2 Report Number 33.Semantic proximity Read ↗

Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular DegenerationSemantic proximity Read ↗

Geographic atrophy in Korean patients with dry age-related macular degeneration: incidence, phenotypes, and progression.Semantic proximity Read ↗

PHENOTYPIC CHARACTERIZATION OF PREDICTORS FOR DEVELOPMENT AND PROGRESSION OF GEOGRAPHIC ATROPHY USING OPTICAL COHERENCE TOMOGRAPHY.Semantic proximity Read ↗

Risk of scar in the comparison of age-related macular degeneration treatments trials.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.